Procter & Gamble Hygiene & Health Care Ltd. (IN:PGHH)
:PGHH
Top Page
Procter & Gamble Hygiene & Health Care Ltd.
(PGHH)
Select Model
Select Model
Rating:65Neutral
Price Target:
₹9,877.00
▼(-22.20% Downside)
Action:ReiteratedDate:03/28/26
The score is anchored by strong financial performance (healthy profitability, low leverage, and solid cash generation), but is significantly tempered by very weak technical signals (downtrend with extremely oversold momentum) and a demanding valuation driven by a very high P/E despite a reasonable dividend yield.
Positive Factors
Low leverage / strong balance sheet
The company's very low debt-to-equity and healthy equity ratio reduce financial risk and preserve strategic flexibility. Low leverage supports resilience in downturns, enables steady reinvestment in brands and distribution, and underpins durable access to capital for growth initiatives.
Negative Factors
Recent revenue weakness
A roughly 44% reported revenue decline is a meaningful structural concern if persistent: it can erode economies of scale, pressure margins, and reduce cash flow. Recovering lost volume or market share in FMCG typically requires sustained brand investment and execution over multiple quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
The company's very low debt-to-equity and healthy equity ratio reduce financial risk and preserve strategic flexibility. Low leverage supports resilience in downturns, enables steady reinvestment in brands and distribution, and underpins durable access to capital for growth initiatives.
Read all positive factors
Procter & Gamble Hygiene & Health Care Ltd. (PGHH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹315.38B
Dividend Yield2.08%
Average Volume (3M)854.00
Price to Earnings (P/E)38.1
Beta (1Y)0.43
Revenue Growth8.28%
EPS Growth11.65%
CountryIN
Employees439
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)N/A
Shares Outstanding32,460,735
10 Day Avg. Volume1,521
30 Day Avg. Volume854
Financial Highlights & Ratios
PEG Ratio2.02
Price to Book (P/B)59.85
Price to Sales (P/S)9.80
P/FCF Ratio78.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)301.03
Revenue Forecast (FY)₹48.38B
Procter & Gamble Hygiene & Health Care Ltd. Business Overview & Revenue Model
Company Description
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. The company provides health care products, including o...
How the Company Makes Money
PGHH primarily makes money by selling branded consumer health and hygiene products in India. Its core revenue model is volume- and brand-led FMCG sales: products are manufactured and/or sourced, then sold to trade customers (distributors/wholesale...
Procter & Gamble Hygiene & Health Care Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.19B | 44.99B | 41.92B | 39.05B | 37.92B | 35.70B |
| Gross Profit | 26.99B | 25.48B | 23.52B | 20.24B | 20.30B | 22.42B |
| EBITDA | 11.78B | 12.11B | 10.23B | 9.09B | 8.54B | 9.24B |
| Net Income | 8.27B | 8.49B | 6.75B | 6.78B | 5.76B | 6.52B |
Balance Sheet | ||||||
| Total Assets | 17.55B | 17.55B | 18.59B | 21.37B | 16.81B | 16.33B |
| Cash, Cash Equivalents and Short-Term Investments | 5.16B | 5.16B | 5.74B | 9.64B | 6.25B | 6.48B |
| Total Debt | 23.20M | 23.20M | 30.80M | 40.30M | 51.00M | 34.70M |
| Total Liabilities | 10.18B | 10.18B | 10.84B | 11.91B | 9.44B | 9.18B |
| Stockholders Equity | 7.37B | 7.37B | 7.75B | 9.46B | 7.38B | 7.14B |
Cash Flow | ||||||
| Free Cash Flow | 5.63B | 5.63B | 4.26B | 7.81B | 5.23B | 8.32B |
| Operating Cash Flow | 6.18B | 6.18B | 4.71B | 8.26B | 5.73B | 8.63B |
| Investing Cash Flow | -586.30M | -586.30M | 10.60M | -99.10M | -268.50M | 69.40M |
| Financing Cash Flow | -6.66B | -6.66B | -8.62B | -4.77B | -5.69B | -11.06B |
Procter & Gamble Hygiene & Health Care Ltd. Technical Analysis
Negative
12694.65
Price Trends
10988.71
Negative
11778.01
Negative
12500.48
Negative
Market Momentum
-439.14
Negative
35.60
Neutral
69.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PGHH, the sentiment is Negative. The current price of 12694.65 is above the 20-day moving average (MA) of 10015.88, above the 50-day MA of 10988.71, and above the 200-day MA of 12500.48, indicating a bearish trend. The MACD of -439.14 indicates Negative momentum. The RSI at 35.60 is Neutral, neither overbought nor oversold. The STOCH value of 69.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PGHH.
Procter & Gamble Hygiene & Health Care Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹503.38B | 43.58 | ― | 2.42% | -2.06% | -9.74% | |
66 Neutral | ₹735.28B | 39.88 | ― | 1.62% | 2.68% | 1.07% | |
66 Neutral | ₹157.74B | -90.62 | ― | 0.28% | 14.55% | -20.61% | |
65 Neutral | ₹315.38B | 38.08 | ― | 2.08% | 8.28% | 11.65% | |
64 Neutral | ₹179.85B | 18.06 | ― | 1.91% | 0.84% | -2.44% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ₹244.50B | 39.50 | ― | 1.39% | 7.42% | 22.99% |
* Consumer Defensive Sector Average
IN:PGHH
Procter & Gamble Hygiene & Health Care Ltd.
9,715.85
-3,839.83
-28.33%
IN:COLPAL
Colgate-Palmolive (India) Limited
1,850.75
-536.30
-22.47%
IN:DABUR
Dabur India Limited
414.55
-37.85
-8.37%
IN:EMAMILTD
Emami Limited
409.60
-158.35
-27.88%
IN:GILLETTE
Gillette India Limited
7,503.50
-244.41
-3.15%
IN:ZYDUSWELL
Zydus Wellness Limited
495.80
149.52
43.18%
Procter & Gamble Hygiene & Health Care Ltd. Corporate Events
P&G Hygiene & Health Care Declares Rs 195 Interim Dividend, Details TDS Rules for FY 2025-26
Jan 30, 2026
Procter Gamble Hygiene and Health Care Limited’s board has declared an interim dividend of Rs 195 per equity share for FY 2025-26, which includes a one-time special dividend of Rs 25 per share, payable to shareholders on record as of Februa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.